ArticleInternational journal of women's health2026
Non-Linear Association Between Serum Estradiol Decline and Clinical Outcomes in IVF/ICSI Cycles: A Retrospective Cohort Study.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The impact of changes in estradiol (E2) levels prior to human chorionic gonadotropin (hCG) administration during controlled ovarian hyperstimulation (COH) on pregnancy and live birth outcomes remains poorly understood. Objective: To study association between serum estradiol decline and clinical outcomes in IVF/ICSI cycles. Materials and Methods: In this retrospective cohort study, we analyzed clinical data from 1113 patients at our reproductive center between January 2016 and December 2017. Peripheral blood samples were collected to measure baseline follicle-stimulating hormone (FSH), luteinizing hormone (LH), and E2, as well as those hormone levels on both stimulation initiation day and hCG administration day. E2 decline was defined as any transient decrease in serum E2 between consecutive measurements (typically 2-3 days apart) during COH, calculated as a percentage change. Results: Participants were stratified into pregnancy (n = 744) and non-pregnancy (n = 369) groups based on clinical outcomes, and further categorized into live birth (n = 677) and non-live birth (n = 436) groups. The mean age of participants was 31.07 ± 4.11 years, with a median infertility duration of 3.00 years (interquartile range: 2.00-5.00). The mean (standard deviation, SD) numbers of previous pregnancies and miscarriages were 0.83 (1.15) and 0.51 (0.89), respectively. Baseline E2, FSH, and LH levels were 171.30 (402.11) pg/mL, 6.90 (1.04) IU/L, and 5.25 (4.04) IU/L, respectively. The mean (SD) change in serum E2 levels on hCG administration day was 2.15 (3.07). Multivariate analysis revealed that a decline in E2 levels was an independently associated with reduced chances of achieving clinical pregnancy (OR = 0.622, 95% CI: 0.424~0.910, Conclusion: A decrease in serum E2 levels before hCG administration was negatively associated with clinical pregnancy and live birth rates in IVF/ICSI cycles, and decreased serum E2 levels exhibited a dose-response relationship with both pregnancy and live birth outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.